Latest Financial Results and Presentations
Latest Financial Results and Presentations
2021 Q3 Results
(Published on 27 Oct 2021)

Next: 2021 Annual Results Announcement

TBC

 
Latest 2021 Q3 Results.
 
Our latest 2021 YTD Q3 Results for the nine months to 30 Sep 2021 saw total revenue and other income up 15 per cent at $16.2 billion. Access latest results: 27 Oct 2021.
()
HKEX Calendar.
HKEX financial announcements and other Investor Relations-related events.
Financial Calendar 2021 >
HKEX Calendar
Shareholder Information.
HKEX's Shareholders Communication Policy ensures that shareholders are provided with ready, equal and timely access to balanced and clear information about HKEX.

 

Dividend.

Year 2021

Basic earnings per share: HK$5.22 (up to 30 June)

Total dividend per share: HK$4.69 (up to 30 June)

Interim Dividend Payment Date: 13 September 2021

Dividend History  >

Unclaimed Dividend  >

 

 

ESG and Sustainability.

Promoting and progressing our financial markets and the communities they support for the prosperity of all, is at the core of everything that we do. Our unique roles and responsibilities as market operator, regulator and listed company define our purpose, and ensure that we place sustainability at the heart of our strategy and our operations.

FTSE Russell ESG Rating
Company rating: 3.8/5
Percentile ranking: 80th (100th is the best)
Hang Seng Indexes ESG Rating
Company rating: AA-
MSCI ESG Rating
Company rating: AA
S&P Global ESG Score
Company score: 62/100
Percentile ranking: 95th (100th is the best)
Q3 2021 Key Highlights
  • Record nine-month revenue and other income of HK$16.2bn (+15%YoY) with core business revenue up by 14%YoY, driven by record Headline ADT
  • Record nine-month Stock Connect revenue and other income of HK$2.1bn (+55%YoY)
  • Profit attributable to shareholders at record nine-month high of HK$9.9bn (+15%YoY)
  • Good performance set against volatile macro backdrop
  • Robust IPO market – #4 globally by IPO funds raised (HK$285.9bn, nine-month record high); Record IPO pipeline
  • Strong Connect scheme performance – record high ADT across all platforms
  • MSCI China A 50 Connect Index Futures launched, providing international investors with a new risk management tool to manage their China exposure
  • SPAC consultation paper published for new listing route in Hong Kong
  • Continued market microstructure, technology enhancements and product launches
  • MOU with HKSTP signed giving HKEX access to HKSTP’s deep pool of biotech industry experts, supporting our biotech listing applications process
2019-2021 Strategic Plan.
Building upon the role we already play as the leading venue for investing into and out of Mainland China, we aim to further increase our international relevance to China and Asia, and our Asia relevance to the global markets, serving as the venue of choice for investors and issuers.

We’re delivering on our commitments to be: China Anchored; Globally Connected; Technology Empowered.